Hospital Raymond Poincare

The Hospital Raymond Poincare leads research on serious bacterial illnesses, focusing on Staphylococcus aureus bacteremia and its impact on patient survival. Current studies aim to lower all‑cause mortality within 90 days by testing a variety of therapeutic strategies.

• Adaptive platform trial design
• Evaluation of antibiotic regimens
• Mortality and long‑term outcome measures
• Biomarker‑guided treatment decisions
• Patient‑focused recovery metrics

The initiative involves two investigators and operates without commercial sponsorship, emphasizing collaborative, evidence‑based improvements for severe bacterial infections.

At this site, researchers address acute respiratory tract infection and community‑acquired pneumonia, seeking to enhance care for hospitalized patients. The primary goal is to assess how diverse interventions affect a composite of 90‑day all‑cause mortality and daily recovery trajectories up to 28 days.

• Multifactorial adaptive trial methodology
• Treatment optimization for pneumonia
• Daily ordinal scale of illness progression
• Integrated safety and efficacy monitoring
• Real‑world hospital patient outcomes

Conducted by a dedicated team of two investigators, the program is non‑commercial and aims to translate findings into faster, more effective therapies for respiratory illnesses.